Immunocore
IMCR
29.41
-0.14
-0.47%
Immunocore
US · IMCR
#2968 by market cap
Listed 2021
29.41
-0.14
-0.47%
Live - 5344 symbols - heartbeat 247s ago
· 2026-10-07 19:54
After-hours
29.41
0.00%
- Market cap
- 1.51B
- P/E (TTM)i
- -79.49
- P/Bi
- 3.61
- EPSi
- -0.71
- Div yieldi
- 0.00%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on IMCR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Buy
Avg price target
62.83 +113.6%
Price target rangecurrent 29.41
Low35.00
Avg62.83
High100.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-21 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-08-21 | J.P. Morgan | -- | BUY | 50.00 |
| 2026-08-12 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-08-07 | Mizuho Securities | -- | HOLD | 35.00 |
| 2026-08-07 | Morgan Stanley | -- | HOLD | 43.00 |
| 2026-08-06 | Needham | -- | BUY | 75.00 |
| 2026-08-06 | Goldman Sachs | -- | BUY | 74.00 |
| 2026-06-03 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-06-01 | Needham | -- | BUY | 75.00 |
| 2026-05-22 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-05-08 | Mizuho Securities | -- | HOLD | 34.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-05-07 | Goldman Sachs | -- | BUY | 73.00 |
| 2026-05-07 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-05-06 | TD Cowen | -- | BUY | 60.00 |
| 2026-05-06 | Needham | -- | BUY | 75.00 |
| 2026-04-23 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-04-20 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-04-20 | Oppenheimer | -- | BUY | 86.00 |
| 2026-04-15 | Mizuho Securities | -- | HOLD | 38.00 |
| 2026-04-14 | Wells Fargo | -- | BUY | 60.00 |
| 2026-04-14 | Needham | -- | BUY | 75.00 |
| 2026-04-14 | H.C. Wainwright | -- | BUY | 100.00 |
| 2026-04-02 | Wells Fargo | -- | BUY | 60.00 |
| 2026-03-15 | Jefferies | -- | HOLD | 33.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±14.51% | +3.63% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±14.99% | -4.51% (in line) |
| 2025/Q2 | 2025-08-07 | -- | ±9.07% | -0.53% (in line) |
| 2024/Q4 | 2025-02-26 | -- | ±17.49% | +5.34% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±16.26% | +2.76% (in line) |
| 2023/Q4 | 2024-02-28 | -- | ±9.82% | -1.76% (in line) |
| 2023/Q2 | 2023-08-10 | -- | ±9.69% | -3.67% (in line) |
| 2022/Q4 | 2023-03-01 | -- | ±16.75% | -1.46% (in line) |
| 2022/Q2 | 2022-08-10 | -- | -- | +4.27% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.